Lv5
1329 积分 2023-03-30 加入
Perioperative Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
14小时前
已完结
Immune checkpoint inhibitors as neoadjuvant therapy for resectable non-small cell lung cancer: a systematic review and network meta-analysis
14小时前
已完结
Perioperative immunotherapy in lung cancer: Time to push the frontiers?
14小时前
求助中
Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges
15小时前
已完结
New territories: perioperative chemoimmunotherapy in early-stage NSCLC
15小时前
已完结
Neoadjuvant or Perioperative Chemoimmunotherapy Treatment in Patients with Resectable NSCLC: Still an Open Question. Comments on Marinelli et al. J Thorac Oncol. 2025;20:285–295
15小时前
求助中
Surgical Impact of Perioperative Immunotherapy in Resectable NSCLC: Insights and Unaddressed Limitations From AEGEAN
15小时前
求助中
Non-small-cell lung cancer
1天前
已完结
Facts and Hopes in Neoadjuvant Immunotherapy Combinations in Resectable Non–Small Cell Lung Cancer
1天前
已完结
Improved Event-Free Survival After Complete or Major Pathologic Response in Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Regardless of Adjuvant Treatment: A Systematic Review and Individual Patient Data Meta-Analysis
1天前
已完结
皖公网安备34019202002308
